- ClearLight Presents Data on the Multiplex 3D Imaging of the Tumor Microenvironment
(posted: Mar, 2017)
ClearLight announced today that it will present data at the 2017 American Association for Cancer Research meeting in Washington DC on Wednesday, April 5, 2017, 8:00 AM-12:00 PM in the Convention Center Halls A-C, poster session 43, board number 27.
- ClearLight Diagnostics Raises $3.5M in Series B Funding
(posted: Dec, 2016)
Clearlight has completed a $3.5M Series B financing round. The financing will go towards the continued technology platform and applications development using the CLARITY technology and deep imaging with COLM Light Sheet Microscopy.
Poster #5915: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue
posted: April 5th, 2017
ClearLight Diagnostics presented its poster #5915 on Wednesday, April 5 at the 2017 American Association for Cancer Research meeting in Washington DC.
The poster, titled: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue illustrates the process of obtaining high-resolution information from solid tumors, while maintaining the spatial perspective needed to understand the heterogeneous tumor microenvironment - addressing a key challenge for preclinical and clinical cancer applications.
For additional information see the original press release.